School of Medicine
Showing 501-550 of 941 Results
-
Kara Meister, MD, FAAP, FACS
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioKara D. Meister, MD, FAAP, FACS is a pediatric otolaryngologist and head & neck surgeon. She received her medical degree from Medical University of South Carolina and completed her otolaryngology residency at University of Pittsburgh. She completed a NIH-funded fellowship in head and neck research at the University of Pittsburgh. Dr. Meister then went on to complete a pediatric otolaryngology fellowship at Lucile Packard Children’s Hospital Stanford.
She is currently an Assistant Professor in the Department Otolaryngology, Division of Pediatric Otolaryngology, at Stanford University. Dr. Meister’s research interests include thyroid cancer, head & neck masses, Graves' disease. She has a special interest in the influence of the environment and pollutants (such as microplastics) on health. She currently serves as the Co-Clinical Chief of Pediatric Otolaryngology. Dr. Meister completed additional training in innovation through the Stanford Biodesign Faculty Fellowship.
Her clinical interests include the treatment of patients with head and neck masses including thyroid nodules and cancer. She is Co-Director, Surgical, of the Children's Thyroid Center at Lucile Packard Children’s Hospital Stanford and is a participating surgeon in the Aerodigestive and Airway Reconstruction Center at Stanford Children’s Health. She is co-editor of the textbook "Pediatric Bronchoscopy for Clinicians" and enjoys advocacy work with the American Academy of Pediatrics Button Battery Taskforce.
Dr. Meister is a member of the American Thyroid Association (ATA) where she serves on the Diversity, Equity, and Inclusion committee and is a member of the ATA Guidelines Writing Group for Thyroid Disease & Pregnancy. She is a member of the pediatric committee of the American Head and Neck Society. She is an author and speaker on masses and tumors of the head and neck, thyroid disease, and thyroid cancer in children and adolescents. In collaboration with SHC, she offers novel treatment for thyroid problems in children and adolescents including radiofrequency ablation of thyroid nodules.
Dr. Meister lives in Woodside with her husband, 3 children, and Rooney the dog.
Clinical Expertise:
Children's Thyroid Center, Co-Director, Surgical
Thyroid nodules
Thyroid cancer - papillary, follicular, and medullary
Surgical management of hyperthyroidism and Grave's disease
MEN syndrome
Head and Neck masses
Congenital neck masses such as branchial cleft cyst, thyroglossal duct cyst
Pediatric Head and Neck cancer
Airway evaluation and reconstruction, voice and swallowing problems, and Aerodigestive
Fetal Airway and Exit Team -
Zariah Mekile
Affiliate, Psychiatry and Behavioral Sciences
BioZariah J. Mekile, MS, MAP, is a doctoral candidate at the PGSP-Stanford Psy.D. Consortium, where she is pursing her PsyD in Clinical Psychology. She completed a BA in psychology with a minor in cognitive science and Spanish at Elizabethtown College, and a Master of Applied Psychology at Rutgers University-Graduate School of Applied and Professional Psychology.
-
Bethlehem Mekonnen, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Mekonnen is a board-certified, fellowship-trained ophthalmologist with the Byers Eye Institute at Stanford Health Care. She is also a clinical assistant professor of medicine in the Department of Ophthalmology.
Dr. Mekonnen diagnoses and treats a wide range of eye conditions, including cataracts, corneal and external eye diseases. She creates an individual, comprehensive care plan for each of her patients.
Dr. Mekonnen’s clinical research interests include exploring the most effective medical and surgical therapies for patients with corneal and external eye diseases. She has researched and published on outcomes of macular edema, described a novel surgical technique for severe ocular surface disease and described a possible new ophthalmic manifestation of a rare congenital disorder called Cobb syndrome.
Dr. Mekonnen has published work in the American Journal of Ophthalmology, Cornea: The Journal of Cornea and External Disease, and the Journal of Ophthalmic Inflammation and Infection. She has presented to her peers at the Association for Research in Vision and Ophthalmology, Women in Ophthalmology (WIO) Summer Symposium, and the Annual GlaxoSmithKline Women in Science Conference.
Dr. Mekonnen is a member of the American Academy of Ophthalmology. -
Mads Melbye
Visiting Professor, Pediatrics - Neonatology
BioMads Melbye, MD, DMSc, is visiting Professor in the Department of Pediatrics at Stanford University School of Medicine. He is also Director of the Danish Cancer Institute (DCI), Research Director at the Danish Cancer Society in Denmark, and Professor in Medical Epidemiology at the Norwegian University of Science and Technology. From 2016-2020 he was President and CEO at Statens Serum Institut, Copenhagen, Denmark. Previous positions at e.g. the National Cancer Institute, NIH, USA, before he became State Epidemiologist in Denmark, and later Head of Department of Epidemiology Research, and Division Director of Epidemiology and Disease Surveillance, Statens Serum Institut. Previous academic positions as Danish Research Council Professor, NORFA professor, and Foreign Adjunct Professor at Karolinska Institute in Sweden. He has written more than 700 publications (H-index: 115/141 (Web of Science/Google scholar) and is the Dane with most papers in high impact journals in general medicine (NEJM, Lancet, JAMA). He is among the worlds top 2% of scientists as listed in the AD Scientific Index 2023. He is knighted by Her Majesty Queen Margrethe II of Denmark, and has received e.g. the Novo Nordisk Prize, the large Erhoff Prize, and the Anders Jahre Prize (young researchers). He is e.g. chairman of the scientific committee at the Danish Health Insurance Fund, member of the scientific advisory board for Oslo University Hospital, member of the A.P. Møller and Chastine Mc-Kinney Møller Foundation (medicine), and board member of the Norwegian Cancer Registry. Has previously served as e.g. chairman of the Governing Council, WHO's International Agency for Research on Cancer in Lyon, France, chairman of the Nordic Medical Research Council’s coordinating body (NOS-M), vice-chairman of the Danish Medical Research Council, chairman of the Ministry of Science, Technology and Innovation's committee on Registry Research (KOR), chairman of the Scientific Council, IARC, Lyon, France, and member of the Novo Nordisk Prize Committee. Together with Professor Stephen Quake he founded Mirvie Inc. in 2018, a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
-
Marc L. Melcher
Stanford Department of Surgery Professor
Current Research and Scholarly InterestsMy goal is to extend the benefits of organ transplantation to greater numbers of patients while maintaining excellent outcomes. We developed the "paired-organ exchange" program at Stanford to increase the chances that patients with willing but incompatible living donors can still receive a living donor kidney. In addition, I am applying artificial intelligence algorithms to facilitate complex decision making in liver transplant.
-
Esmeralda Melgoza
Postdoctoral Scholar, Emergency Medicine
BioEsmeralda Melgoza, PhD, MPH, CHES is a postdoctoral researcher in the Department of Emergency Medicine at Stanford University's School of Medicine. Her research examines health inequities in the U.S. healthcare system, with a focus on emergency medical services provided in the prehospital setting and the emergency department. She centers her research on the experiences of underserved populations, including Latine/Hispanics, older adults, and people with limited English proficiency. She is trained in both quantitative and qualitative methods. Her research has been published in peer-reviewed journals, including Medical Care, the Journal of the American Heart Association, Health Affairs Scholar, Prehospital Emergency Care, and SSM-Qualitative Research in Health, among others. She is a current recipient of a grant from the CARESTAR Foundation.
Dr. Melgoza received her PhD in Community Health Sciences from the UCLA Fielding School of Public Health and a minor in Gerontology from the USC Leonard Davis School of Gerontology. Her dissertation research was funded by an R36 grant from the National Institute on Aging. Dr. Melgoza is a former Senior Research Analyst at the UCLA Latino Policy and Politics Institute and an alumna of the Yale Ciencia Academy at Yale University. She is bilingual in English and Spanish. In her spare time, she enjoys spending time with her family, traveling, mentoring, and hiking. -
Elizabeth Mellins
Member, Bio-X
Current Research and Scholarly InterestsMolecular mechanisms and intracellular pathways of MHC class II antigen processing and presentation, with a focus on B cells; mechanisms underlying HLA allele association with disease; disease mechanisms in systemic juvenile idiopathic arthritis, including an HLA-linked complication; monocytes as drivers or suppressors of auto-inflammation in systemic juvenile idiopathic arthritis and pediatric acute neuropsychiatric syndrome.
-
Michelle Mello
Professor of Law and of Health Policy
BioMichelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine. She conducts empirical research into issues at the intersection of law, ethics, and health policy. She is the author of more than 250 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, artificial intelligence, health information privacy, and other topics.
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40. From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
Dr. Mello teaches courses in torts and public health law. She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. -
Nicholas Melosh
Professor of Materials Science and Engineering
BioThe Melosh group explores how to apply new methods from the semiconductor and self-assembly fields to important problems in biology, materials, and energy. We think about how to rationally design engineered interfaces to enhance communication with biological cells and tissues, or to improve energy conversion and materials synthesis. In particular, we are interested in seamlessly integrating inorganic structures together with biology for improved cell transfection and therapies, and designing new materials, often using diamondoid molecules as building blocks.
My group is very interested in how to design new inorganic structures that will seamless integrate with biological systems to address problems that are not feasible by other means. This involves both fundamental work such as to deeply understand how lipid membranes interact with inorganic surfaces, electrokinetic phenomena in biologically relevant solutions, and applying this knowledge into new device designs. Examples of this include “nanostraw” drug delivery platforms for direct delivery or extraction of material through the cell wall using a biomimetic gap-junction made using nanoscale semiconductor processing techniques. We also engineer materials and structures for neural interfaces and electronics pertinent to highly parallel data acquisition and recording. For instance, we have created inorganic electrodes that mimic the hydrophobic banding of natural transmembrane proteins, allowing them to ‘fuse’ into the cell wall, providing a tight electrical junction for solid-state patch clamping. In addition to significant efforts at engineering surfaces at the molecular level, we also work on ‘bridge’ projects that span between engineering and biological/clinical needs. My long history with nano- and microfabrication techniques and their interactions with biological constructs provide the skills necessary to fabricate and analyze new bio-electronic systems.
Research Interests:
Bio-inorganic Interface
Molecular materials at interfaces
Self-Assembly and Nucleation and Growth -
Kathryn Melsop
Director, Finance & Facility Operations, Stanford Laboratory for Cell and Gene Medicine
Current Role at StanfordDirector, Finance and Facility Operations at the Laboratory for Cell & Gene Medicine.
-
Hector Mendez
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Hector Rodrigo Mendez is a Medical Geneticist from Argentina. Rodrigo completed a residency program in Medical Genetics at Centro Nacional de Genetica Medica – ANLIS (Buenos Aires, Argentina) and a Master’s program in Medical Molecular Biology at Buenos Aires University.
Rodrigo continued his scientific career at a German Genomic Start-up, working as a human geneticist and providing his experience in rare disorders, genomic data (WGS/WES/gene panels) analysis, variant interpretation, and its integration with a deep focus on genotype-phenotype correlation.
Rodrigo’s areas of expertise are rare disorders, NGS technology, Whole Genome Sequencing analysis, and ACMG interpretation guidelines, and his research aims are:
- Collection and analysis of clinical data through deep-learning phenotyping approaches.
- Multi-omic data integration to elucidate complex and rare genetic disorders.
- Drive progress in curing rare genetic diseases, particularly among critically sick infants.
At Stanford University, under the supervision of Dr. Matthew Wheeler, he is conducting his postdoctoral research studies to achieve his scientific goals. -
Fernando S. Mendoza
Associate Dean of Minority Advising and Programs and Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsI have two research interests: childhood health disparities and workforce diversity. My research on childhood health disparities centers on Latino and immigrant children with a focus on early childhood health and development. My work in workforce diversity examines the pipeline for diversity in academic pediatrics, with special attention on the pipeline for underrepresent minorities.
-
Joshua Menke
Clinical Associate Professor, Pathology
BioDr. Joshua Menke completed his hematopathology fellowship at Stanford and a cytopathology fellowship at the University of California, San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology, and advanced single-cell and cell-free diagnostic techniques. As the Associate Section Director of Clinical Flow Cytometry at Stanford, Dr. Menke is developing and validating new minimal residual disease assays for detecting low levels of myeloid and lymphoid neoplasms in the post-treatment setting, as well as multiple other 12-color flow assays with the latest markers for routine phenotyping.
Dr. Menke is the recipient of the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and the Laurence J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboratory. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitutional Collaboration (CHIC), which aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions. He currently chairs this group, leading large clinical research studies. -
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology and Neurological Sciences
On Partial Leave from 12/16/2025 To 03/15/2026Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Antonio Meola, MD, PhD
BioAntonio Meola M.D. Ph.D graduated Summa cum Laude and Research Honors at the University of Pisa, Italy, in 2008, and completed his residency training in Neurosurgery at the same Institution in July 2015. Dr Meola attended a Ph.D. program at the University of Florence, Italy, where he discussed a doctoral thesis entitled "A New Head-Mounted Display-based Augmented Reality System in Neurosurgical Oncology: a study on phantom".
Since 2/2014 to 1/2015 Dr Meola completed a Research Fellowship in Neurosurgical anatomy at the University of Pittsburgh Medical Center (UPMC), under the Direction of Dr. Juan C. Fernandez-Miranda. The main focus of his research was the surgical neuroanatomy of the white matter tracts of the human brain.
Since 7/2015 to 6/2016 Dr Meola served as Clinical Fellow in Image-Guided Neurosurgery at the Brigham and Women's Hospital, Harvard Medical School, in Boston, MA (Director: Dr. Alexandra J. Golby M.D.). During the fellowship, he focused on the clinical application and integration of advanced imaging techniques, including intraoperative-MRI, intraoperative US, functional MRI, tractography.
Since 7/2016 to 6/2017 Dr Meola completed a Neurosurgical Oncology Fellowship at the Cleveland Clinic in Cleveland, OH, devoting his efforts to minimally-invasive neurosurgical techniques, such as Laser interstitial Thermal Therapy (LITT) and stereotactic radiosurgery (Gamma Knife), as well as to awake neurosurgery.
Starting 7/2017, Dr Meola joined the Department of Neurosurgery at Stanford. Dr. Meola mainly focuses on conventional and innovative treatments for brain and skull base tumors, including both surgery and stereotactic radiosurgery (CyberKnife). -
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Sylvia Bereknyei Merrell
Causal temp, Pediatrics - General Pediatrics
Current Role at StanfordResearcher teaching about qualitative research in General Pediatrics. Co-Director of the Medical Education Scholarly Concentration program for the School of Medicine.
